Microbiome analysis in individuals with human papillomavirus oral infection

From BugSigDB
Needs review
study design
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Journal
Sci. Rep.
Year
Pages:
13
First page:
Introduction"Introduction" is not a number.
Keywords:
Microbiome , HIV, Human Papillomavirus
This study looked at how the oral microbiome (the bacteria in the mouth) is affected by human papillomavirus (HPV) infection, especially in people with and without HIV. Researchers analyzed mouth rinse samples from 63 men, comparing their bacterial composition based on whether they had HPV and/or HIV.

They found that HPV infection changes the diversity and types of bacteria in the mouth, but these changes were different depending on whether the person also had HIV. In HIV-negative individuals, certain bacteria were more common when HPV was present, while in HIV-positive individuals, different bacterial shifts were observed.

The study suggests that HPV infection interacts with the oral microbiome in unique ways, and this interaction may be influenced by HIV status.

Experiment 1


Needs review

Curated date: 2025/03/27

Curator: Uzy-tessy

Revision editor(s): Uzy-tessy, Tosin

Subjects

Location of subjects
Italy
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Mouth Adult mouth,Cavital oralis,Cavitas oris,Cavum oris,Mouth cavity,Oral region,Oral vestibule,Regio oralis,Rima oris,Stoma,Stomatodaeum,Trophic apparatus,Vestibule of mouth,Vestibulum oris,Mouth,mouth
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Human papilloma virus infection HPV,Human Papilloma Virus Infection,Human papilloma Virus infection,human papilloma virus infection,Human papillomavirus caused disease or disorder,Human papillomavirus disease or disorder,Human Papillomavirus Infection,Human Papillomavirus infection,Human papillomavirus infectious disease,Human papilloma virus infection
Group 0 name Corresponds to the control (unexposed) group for case-control studies
HIV-/HPV- (Human immuno deficiency virus negative/Human papilloma virus negative)
Group 1 name Corresponds to the case (exposed) group for case-control studies
HIV-/hrHPV+ (Human immuno deficiency virus negative/ High risk human papilloma virus positive)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
HIV (Human Immunodeficiency Virus) negative Patients with High risk human papillomavirus (HPV) oral infection.
Group 0 sample size Number of subjects in the control (unexposed) group
20
Group 1 sample size Number of subjects in the case (exposed) group
21

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
raw counts
Statistical test
Linear Regression
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
Matched on Factors on which subjects have been matched on in a case-control study
age, alcohol consumption measurement, smoking status, oral hygiene, Matched on: "HIV status" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.HIV status
Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
age, Confounders controlled for: "sexual behaviour" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.sexual behaviour, education level, household income, alcohol consumption measurement, oral hygiene, Confounders controlled for: "STI history" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.STI history, smoking status

Alpha Diversity

Pielou Quantifies how equal the community is numerically
unchanged
Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
increased
Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
unchanged

Signature 1

Needs review

Curated date: 2025/03/30

Curator: Uzy-tessy

Revision editor(s): Uzy-tessy, Tosin

Source: Figure 4, supplementary Figure 2

Description: Differential abundance of oral bacterial taxa at the genus and species level.

Abundance in Group 1: increased abundance in HIV-/hrHPV+ (Human immuno deficiency virus negative/ High risk human papilloma virus positive)

NCBI Quality ControlLinks
Aggregatibacter sp. oral taxon 513
Gracilibacteria bacterium oral taxon 873
Moraxella
Parvimonas
Porphyromonas
Porphyromonas gingivalis
Prevotella sp. oral taxon 376
Prevotella sp. oral taxon 443
Sneathia
Lachnospiraceae (G-8)Lachnospiraceae (G-8)
Absconditabacteria (SR-1) (G-1) bacterium HMT 874Absconditabacteria (SR-1) (G-1) bacterium HMT 874
Schaalia sp. HMT 178Schaalia sp. HMT 178
Bergeyella sp. HMT 206Bergeyella sp. HMT 206
Moraxella sp. HMT 276Moraxella sp. HMT 276
Bacteroidales (G-2)Bacteroidales (G-2)
Gracilibacteria (GN02) (G-2)Gracilibacteria (GN02) (G-2)
Bacteroidales (G-2) bacterium HMT 274Bacteroidales (G-2) bacterium HMT 274
Bacteroidetes (G-5)Bacteroidetes (G-5)
Bacteroidetes bacterium oral taxon 507
Lachnospiraceae bacterium oral taxon 500
Veillonellaceae bacterium oral taxon 150

Revision editor(s): Uzy-tessy, Tosin

Signature 2

Needs review

Curated date: 2025/03/31

Curator: Uzy-tessy

Revision editor(s): Uzy-tessy, Tosin

Source: Figure 4, supplementary Figure 2

Description: Differential abundance of oral bacteria taxa at the genus and specie level.

Abundance in Group 1: decreased abundance in HIV-/hrHPV+ (Human immuno deficiency virus negative/ High risk human papilloma virus positive)

NCBI Quality ControlLinks
Alloscardovia
Alloscardovia omnicolens
Cutibacterium
Cutibacterium acnes
Fusobacterium gonidiaformans
Leptotrichia wadei
Limosilactobacillus fermentum
Neisseria sp. oral taxon 020
Prevotella histicola
Prevotella sp. oral taxon 292
Prevotella sp. oral taxon 313
Stomatobaculum longum
TM7 phylum sp. oral taxon 349
Peptostreptococcaceae (XI) (G-1) Eubacterium infirmumPeptostreptococcaceae (XI) (G-1) Eubacterium infirmum

Revision editor(s): Uzy-tessy, Tosin

Experiment 2


Needs review

Curated date: 2025/04/07

Curator: Uzy-tessy

Revision editor(s): Uzy-tessy, Tosin

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
HIV+/HPV- (Human immuno deficiency virus positive / Human papilloma virus negative)
Group 1 name Corresponds to the case (exposed) group for case-control studies
HIV+/hrHPV+ (Human immuno deficiency virus positive/ High risk Human papilloma virus positive)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
HIV (Human Immunodeficiency Virus) positive Patients with High risk human papillomavirus (HPV) oral infection.
Group 0 sample size Number of subjects in the control (unexposed) group
10
Group 1 sample size Number of subjects in the case (exposed) group
12

Lab analysis

Statistical Analysis

Matched on Factors on which subjects have been matched on in a case-control study
age, alcohol consumption measurement, smoking status, oral hygiene, Matched on: "HIV status" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.HIV status, Matched on: "cART therapy" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.cART therapy
Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
age, education level, household income, Confounders controlled for: "sexual behaviour" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.sexual behaviour, Confounders controlled for: "STI history" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.STI history, smoking status, oral hygiene, alcohol consumption measurement

Alpha Diversity

Pielou Quantifies how equal the community is numerically
unchanged
Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged
Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
unchanged

Signature 1

Needs review

Curated date: 2025/04/07

Curator: Uzy-tessy

Revision editor(s): Uzy-tessy, Tosin

Source: Figure 4, supplementary Figure 2

Description: Differential abundance of oral bacteria taxa at the genus and specie level.

Abundance in Group 1: increased abundance in HIV+/hrHPV+ (Human immuno deficiency virus positive/ High risk Human papilloma virus positive)

NCBI Quality ControlLinks
Actinomyces radicidentis
Atopobium sp. oral taxon 416
Bacteroidetes bacterium oral taxon 280
Bacteroidetes bacterium oral taxon 516
Bulleidia
Capnocytophaga sp. oral taxon 336
Catonella sp. oral taxon 451
Hoylesella oralis
Klebsiella
Lactobacillus iners
Oribacterium sp. oral taxon 078
Peptoniphilus
Prevotella sp. oral taxon 300
Prevotella sp. oral taxon 315
Simonsiella
Lachnospiraceae (G-7)Lachnospiraceae (G-7)
Porphyromonas sp. HMT 930Porphyromonas sp. HMT 930
Oribacterium parvum
Peptoniphilus lacrimalis
Bulleidia extructa
Aggregatibacter aphrophilus
Treponema sp. oral taxon 271
Fretibacterium fastidiosum

Revision editor(s): Uzy-tessy, Tosin

Signature 2

Needs review

Curated date: 2025/04/07

Curator: Uzy-tessy

Revision editor(s): Uzy-tessy, Tosin

Source: Figure 4, supplementary Figure 2

Description: Differential abundance of oral bacteria taxa at the genus and specie level.

Abundance in Group 1: decreased abundance in HIV+/hrHPV+ (Human immuno deficiency virus positive/ High risk Human papilloma virus positive)

NCBI Quality ControlLinks
Acidovorax
Bacteroidetes bacterium oral taxon 436
Bergeyella sp. oral taxon 422
Fastidiosipila sanguinis
Gracilibacteria bacterium oral taxon 871
Leptotrichia hofstadii
Megasphaera sp. oral taxon 123
Mitsuokella sp. oral taxon 521
Novosphingobium panipatense
Porphyromonas sp. oral taxon 275
Prevotella aurantiaca
Prevotella sp. oral taxon 306
TM7 phylum sp. oral taxon 355
Tannerella serpentiformis
Treponema sp. oral taxon 227
Treponema sp. oral taxon 265
Veillonella rogosae
[Acidovorax] ebreus
Gracilibacteria (GN02) (G-2)Gracilibacteria (GN02) (G-2)
Gracilibacteria (GN02) (G-1)Gracilibacteria (GN02) (G-1)
Saccharibacteria (TM7) (G-4)Saccharibacteria (TM7) (G-4)
Porphyromonas sp. HMT 285Porphyromonas sp. HMT 285
Peptostreptococcaceae (XI) (G-8) bacterium HMT 382Peptostreptococcaceae (XI) (G-8) bacterium HMT 382
Syntrophomonadaceae bacterium oral taxon 435

Revision editor(s): Uzy-tessy, Tosin